Increase in treatment compliance reveals new options of treatment of gastroesophageal reflux disease
The aim of review. To present update on the causes of insufficient treatment response to proton pump inhibitors (PPI) at gastroesophageal reflux disease (GERD) and to inform on the options of increasing patients’ compliance.Summary. Decline of treatment compliance remains to be one of the principal...
Saved in:
Main Authors: | Yu. V. Yevsyutina, A. S. Trukhmanov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Gastro LLC
2015-05-01
|
Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
Subjects: | |
Online Access: | https://www.gastro-j.ru/jour/article/view/997 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gastroesophageal reflux disease, resistant to proton pump inhibitors
by: V. O. Kaybysheva, et al.
Published: (2011-06-01) -
Contemporary Approaches to the Treatment of Gastroesophageal Reflux Disease
by: Boris D. Starostin
Published: (2019-03-01) -
New opinion on the issue of proton pump inhibitor-refractory gastroesophageal reflux disease
by: Yu. V. Yevsyutina, et al.
Published: (2014-11-01) -
Current management of proton pump inhibitor-refractory gastroesophageal reflux disease
by: V. V. Tsukanov, et al.
Published: (2020-06-01) -
ESTIMATION OF CLINICAL AND PHARMACOECONOMIC EFFICIENCY OF PROTON PUMP INHIBITORS DURING GASTROESOPHAGEAL REFLUX DISEASE (GERD) TREATMENT
by: N. E. Shabanova, et al.
Published: (2018-12-01)